Literature DB >> 29280351

MiR-27b-3p Regulation in Browning of Human Visceral Adipose Related to Central Obesity.

Jing Yu1, Yifan Lv1, Wenjuan Di1, Juan Liu1, Xiaocen Kong1, Yunlu Sheng1, Min Huang1, Shan Lv1, Hanmei Qi1, Mei Gao2, Hui Liang3, Sarah Kim4, Zan Fu3, Hong Zhou4, Guoxian Ding1.   

Abstract

OBJECTIVE: Given the rising prevalence of central obesity and the discovery that beige cells appear within white adipose tissue, strategies to enhance these energy-expending adipocytes or "browning" within white adipose depots have become of therapeutic interest to combat obesity and its associated disorders. This study focused on, the role of microRNA (miRNA)-27b-3p in human visceral adipose tissue (VAT) browning.
METHODS: Expression of miR-27b-3p and UCP1 in VAT and serum of humans was measured. MiR-27b-3p was overexpressed or suppressed in human visceral stromal fraction cells to analyze the potential role of miR-27b-3p.
RESULTS: UCP1 expression in human VAT decreased with elevated BMI and waist-hip ratio, whereas expression of miR-27b-3p was found to correlate positively with BMI and waist-hip ratio. High expression of miR-27b-3p was associated with reduced browning ability of human visceral adipocytes. Antagonism of miR-27b-3p led to the enhancement of browning ability in human visceral adipocytes.
CONCLUSIONS: These findings highlight the decreased browning ability of VAT from humans with obesity and the role of miR-27b-3p in regulating browning of human visceral adipocytes. They suggest that miR-27b-3p should be further explored as a potential target for the treatment of central obesity.
© 2017 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29280351     DOI: 10.1002/oby.22104

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  7 in total

Review 1.  The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis.

Authors:  Lin Ru; Xiao-Mei Wang; Jun-Qi Niu
Journal:  Acta Pharmacol Sin       Date:  2021-12-10       Impact factor: 7.169

2.  miR-1185-1 and miR-548q Are Biomarkers of Response to Weight Loss and Regulate the Expression of GSK3B.

Authors:  Marcos Garcia-Lacarte; Maria L Mansego; M Angeles Zulet; J Alfredo Martinez; Fermin I Milagro
Journal:  Cells       Date:  2019-11-30       Impact factor: 6.600

3.  MicroRNA-188 regulates aging-associated metabolic phenotype.

Authors:  Yan Huang; Ye Xiao; Ya Liu; Min Guo; Qi Guo; Fangliang Zhou; Ting Liu; Tian Su; Yuzhong Xiao; Xiang-Hang Luo
Journal:  Aging Cell       Date:  2019-11-25       Impact factor: 9.304

4.  Neuronally-enriched exosomal microRNA-27b mediates acute effects of ibuprofen on reward-related brain activity in healthy adults: a randomized, placebo-controlled, double-blind trial.

Authors:  Kaiping Burrows; Leandra K Figueroa-Hall; Rayus Kuplicki; Jennifer L Stewart; Ahlam M Alarbi; Rajagopal Ramesh; Jonathan B Savitz; T Kent Teague; Victoria B Risbrough; Martin P Paulus
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

Review 5.  Regulation of Adipose Thermogenesis and its Critical Role in Glucose and Lipid Metabolism.

Authors:  Linghui Wang; Yanhao Qiu; Hao Gu; Mailin Gan; Yan Zhu; Kangping Zhu; Lei Chen; Ye Zhao; Lili Niu; Shunhua Zhang; Xuewei Li; Li Zhu; Linyuan Shen
Journal:  Int J Biol Sci       Date:  2022-07-27       Impact factor: 10.750

6.  A neurogenic signature involving monoamine Oxidase-A controls human thermogenic adipose tissue development.

Authors:  Javier Solivan-Rivera; Zinger Yang Loureiro; Tiffany DeSouza; Anand Desai; Sabine Pallat; Qin Yang; Raziel Rojas-Rodriguez; Rachel Ziegler; Pantos Skritakis; Shannon Joyce; Denise Zhong; Tammy Nguyen; Silvia Corvera
Journal:  Elife       Date:  2022-09-15       Impact factor: 8.713

7.  MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.

Authors:  Guoqi Li; Yihui Shao; Hong Chang Guo; Ying Zhi; Bokang Qiao; Ke Ma; Jie Du; Yong Qiang Lai; Yulin Li
Journal:  Cardiovasc Res       Date:  2022-07-20       Impact factor: 13.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.